183 related articles for article (PubMed ID: 29332262)
1. Tumor expression of survivin, p53, cyclin D1, osteopontin and fibronectin in predicting the response to neo-adjuvant chemotherapy in children with advanced malignant peripheral nerve sheath tumor.
Karpinsky G; Krawczyk MA; Izycka-Swieszewska E; Fatyga A; Budka A; Balwierz W; Sobol G; Zalewska-Szewczyk B; Rychlowska-Pruszynska M; Klepacka T; Dembowska-Baginska B; Kazanowska B; Gabrych A; Bien E
J Cancer Res Clin Oncol; 2018 Mar; 144(3):519-529. PubMed ID: 29332262
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical assessment of cyclin D1 and p53 is associated with survival in childhood malignant peripheral nerve sheath tumor.
Krawczyk MA; Karpinsky G; Izycka-Swieszewska E; Gabrych A; Kunc M; Fatyga A; Garstka M; Styczewska M; Sokolewicz EM; Szlagatys-Sidorkiewicz A; Kazanowska B; Bien E
Cancer Biomark; 2019; 24(3):351-361. PubMed ID: 30883338
[TBL] [Abstract][Full Text] [Related]
3. Tumour expressions of hypoxic markers predict the response to neo-adjuvant chemotherapy in children with inoperable rhabdomyosarcoma.
Krawczyk MA; Styczewska M; Sokolewicz EM; Kunc M; Gabrych A; Fatyga A; Izycka-Swieszewska E; Kazanowska B; Adamkiewicz-Drozynska E; Bien E
Biomarkers; 2019 Sep; 24(6):538-548. PubMed ID: 30995126
[No Abstract] [Full Text] [Related]
4. Survivin expression and prognostic significance in pediatric malignant peripheral nerve sheath tumors (MPNST).
Alaggio R; Turrini R; Boldrin D; Merlo A; Gambini C; Ferrari A; Dall'igna P; Coffin CM; Martines A; Bonaldi L; De Salvo GL; Zanovello P; Rosato A
PLoS One; 2013; 8(11):e80456. PubMed ID: 24303016
[TBL] [Abstract][Full Text] [Related]
5. Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO).
Valentin T; Le Cesne A; Ray-Coquard I; Italiano A; Decanter G; Bompas E; Isambert N; Thariat J; Linassier C; Bertucci F; Bay JO; Bellesoeur A; Penel N; Le Guellec S; Filleron T; Chevreau C
Eur J Cancer; 2016 Mar; 56():77-84. PubMed ID: 26824706
[TBL] [Abstract][Full Text] [Related]
6. MMP-13 and p53 in the progression of malignant peripheral nerve sheath tumors.
Holtkamp N; Atallah I; Okuducu AF; Mucha J; Hartmann C; Mautner VF; Friedrich RE; Mawrin C; von Deimling A
Neoplasia; 2007 Aug; 9(8):671-7. PubMed ID: 17786186
[TBL] [Abstract][Full Text] [Related]
7. Survivin is a viable target for the treatment of malignant peripheral nerve sheath tumors.
Ghadimi MP; Young ED; Belousov R; Zhang Y; Lopez G; Lusby K; Kivlin C; Demicco EG; Creighton CJ; Lazar AJ; Pollock RE; Lev D
Clin Cancer Res; 2012 May; 18(9):2545-57. PubMed ID: 22407831
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
[TBL] [Abstract][Full Text] [Related]
9. Malignant peripheral nerve sheath tumor of intracranial nerve: a case series review.
Ziadi A; Saliba I
Auris Nasus Larynx; 2010 Oct; 37(5):539-45. PubMed ID: 20399579
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of C-X-C motif chemokine receptor 4 in patients with sporadic malignant peripheral nerve sheath tumors.
Zhang C; Chang FY; Zhou WY; Yang JL
Chin J Cancer; 2017 Oct; 36(1):80. PubMed ID: 29020982
[TBL] [Abstract][Full Text] [Related]
11. Pediatric malignant peripheral nerve sheath tumor: the Italian and German soft tissue sarcoma cooperative group.
Carli M; Ferrari A; Mattke A; Zanetti I; Casanova M; Bisogno G; Cecchetto G; Alaggio R; De Sio L; Koscielniak E; Sotti G; Treuner J
J Clin Oncol; 2005 Nov; 23(33):8422-30. PubMed ID: 16293873
[TBL] [Abstract][Full Text] [Related]
12. Serum biomarkers for neurofibromatosis type 1 and early detection of malignant peripheral nerve-sheath tumors.
Park SJ; Sawitzki B; Kluwe L; Mautner VF; Holtkamp N; Kurtz A
BMC Med; 2013 Apr; 11():109. PubMed ID: 23618374
[TBL] [Abstract][Full Text] [Related]
13. Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcome.
Zou C; Smith KD; Liu J; Lahat G; Myers S; Wang WL; Zhang W; McCutcheon IE; Slopis JM; Lazar AJ; Pollock RE; Lev D
Ann Surg; 2009 Jun; 249(6):1014-22. PubMed ID: 19474676
[TBL] [Abstract][Full Text] [Related]
14. cDNA microarray analysis of cancer associated gene expression profiles in malignant peripheral nerve sheath tumours.
Karube K; Nabeshima K; Ishiguro M; Harada M; Iwasaki H
J Clin Pathol; 2006 Feb; 59(2):160-5. PubMed ID: 16443732
[TBL] [Abstract][Full Text] [Related]
15. Survivin as a predictive biomarker of complete pathologic response to neoadjuvant chemotherapy in patients with stage II and stage III breast cancer.
Petrarca CR; Brunetto AT; Duval V; Brondani A; Carvalho GP; Garicochea B
Clin Breast Cancer; 2011 Apr; 11(2):129-34. PubMed ID: 21569999
[TBL] [Abstract][Full Text] [Related]
16. Calebin-A induced death of malignant peripheral nerve sheath tumor cells by activation of histone acetyltransferase.
Lee MJ; Tsai YJ; Lin MY; You HL; Kalyanam N; Ho CT; Pan MH
Phytomedicine; 2019 Apr; 57():377-384. PubMed ID: 30831486
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment with doxorubicin and ifosfamide for mediastinal malignant peripheral nerve sheath tumor with loss of H3K27me3 expression.
Seno N; Fukushima T; Gomi D; Kobayashi T; Sekiguchi N; Matsushita H; Ozawa T; Tsukahara Y; Mamiya K; Koizumi T; Sano K
Thorac Cancer; 2017 Nov; 8(6):720-723. PubMed ID: 28876532
[TBL] [Abstract][Full Text] [Related]
18. Malignant Peripheral Nerve Sheath Tumor of the Femur: A Rare Diagnosis Supported by Complete Immunohistochemical Loss of H3K27me3.
Sugawara M; Kobayashi E; Asano N; Yoshida A; Kawai A
Int J Surg Pathol; 2017 Oct; 25(7):629-634. PubMed ID: 28508686
[TBL] [Abstract][Full Text] [Related]
19. A neurogenic tumor containing a low-grade malignant peripheral nerve sheath tumor (MPNST) component with loss of p16 expression and homozygous deletion of CDKN2A/p16: a case report showing progression from a neurofibroma to a high-grade MPNST.
Tajima S; Koda K
Int J Clin Exp Pathol; 2015; 8(5):5113-20. PubMed ID: 26191206
[TBL] [Abstract][Full Text] [Related]
20. Malignant peripheral nerve sheath tumors (MPNST) in NF1-affected children.
Friedrich RE; Hartmann M; Mautner VF
Anticancer Res; 2007; 27(4A):1957-60. PubMed ID: 17649804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
